Primary Intraventricular Hemorrhage in Pediatric Patients: Causes, Characteristics, and Outcomes

Rui Guo1, Ruiqi Chen1, Zhiyuan Yu1

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

World Neurosurgery
|September 3, 2019
PubMed

Insights

Primary intraventricular hemorrhage (PIVH) in children is rare, with arteriovenous malformations being the most common cause. Higher Graeb scores predict poor outcomes, highlighting the need for targeted surgical treatment.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Vascular Malformations

Background:

  • Primary intraventricular hemorrhage (PIVH) is a rare condition in children with poorly understood causes and outcomes.
  • Limited data exists on the specific characteristics and prognostic factors of PIVH in pediatric populations.

Purpose of the Study:

  • To investigate the causes, clinical characteristics, and outcomes of primary intraventricular hemorrhage in pediatric patients.
  • To identify factors associated with unfavorable outcomes in children with PIVH.

Main Methods:

  • Retrospective analysis of 18 pediatric patients (1 month to 21 years) with PIVH over a 7-year period.
  • PIVH defined as hemorrhage confined to the ventricular system.
  • Clinical data, etiologies, treatments, and outcomes (including Graeb score) were reviewed.

Main Results:

  • Arteriovenous malformations (66.7%) were the leading cause of PIVH, followed by moyamoya disease and aneurysms.
  • Headache and vomiting were the most frequent presenting symptoms.
  • A higher Graeb score correlated with unfavorable short-term and long-term outcomes.

Conclusions:

  • Arteriovenous malformations are the predominant etiology for PIVH in children.
  • Surgical intervention targeting the underlying cause is crucial for clinical improvement.
  • Elevated Graeb scores at admission are indicative of poor prognosis in pediatric PIVH cases.
Abstract

Related Concept Videos

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin04:51

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

This video demonstrates a method to generate a rat model of neonatal intraventricular hemorrhage. In this procedure, an anesthetized rat pup is injected with hemoglobin into the lateral ventricle of the brain. The hemoglobin causes oxidative stress and releases heme, simulating intraventricular hemorrhage. The resulting damage to brain tissues, driven by reactive oxygen species and inflammatory cytokines, leads to ventricular enlargement, a common consequence of intraventricular...
441
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

We present a model of neonatal intraventricular hemorrhage using rat pups that mimics the pathology seen in...
3.4K
Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model08:18

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Monitoring intracranial pressure in rodent models of nontraumatic intraventricular hemorrhage is not common in the current literature. Herein, we demonstrate a technique for measuring intracranial pressure, mean arterial pressure, and cerebral perfusion pressure during intraventricular hemorrhage in a rat animal...
2.9K
Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

This article provides comprehensive step-by-step instructions for the acquisition of whole-body 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) PET/MRI scans for cancer staging of pediatric patients. The protocol was developed for children above 6 years, or old enough to comply with breath-hold instructions, but can be used for general anesthesia patients as...
15.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
261